Trials and TRIPS-ulations: Indian patent law and Novartis ag v. Union of India
When pharmaceutical company Novartis challenged the rejection of its patent application for the leukemia drug Gleevec in Novartis AG v. Union of India, it became the first major legal challenge to India’s